Literature DB >> 21074267

It takes two-to-leukemia: about addictions and requirements.

Rolf Marschalek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074267     DOI: 10.1016/j.leukres.2010.10.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  4 in total

Review 1.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

Review 2.  Mouse models of MLL leukemia: recapitulating the human disease.

Authors:  Thomas A Milne
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.

Authors:  Adam C Wilkinson; Erica Ballabio; Huimin Geng; Phillip North; Marta Tapia; Jon Kerry; Debabrata Biswas; Robert G Roeder; C David Allis; Ari Melnick; Marella F T R de Bruijn; Thomas A Milne
Journal:  Cell Rep       Date:  2013-01-24       Impact factor: 9.423

Review 4.  Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.

Authors:  Rolf Marschalek
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.